Biological characteristics of the pure antiestrogen fulvestrant: overcoming endocrine resistance

By Dowsett Mitch   Nicholson Robert   Pietras Richard  

Breast Cancer Research and Treatment, Vol. 93, Iss. 4, 2005-10 ,pp. : 11-18

Springer Publishing Company

Access to resources Recommend Favorite

Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-03 ,pp. : 464-475

Bentham Science Publishers

Access to resources Recommend Favorite

Spotlight on Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression Following Antiestrogen Therapy

By Kate McKeage   Monique P. Curran   Greg L. Plosker  

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 267-270

Adis International

Access to resources Recommend Favorite

Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780

By Lim K.B.   Ng C.Y.   Ong C.K.   Ong C.S.   Tran E.   Nguyen T.T.T.   Chan G.M.T.W.   Huynh H.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 2, 2001-07 ,pp. : 127-138

Springer Publishing Company

Access to resources Recommend Favorite

Postmenopausal Women who Progress on Fulvestrant (‘Faslodex’) Remain Sensitive to Further Endocrine Therapy

By Vergote I.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 2, 2003-05 ,pp. : 207-211

Springer Publishing Company

Access to resources Recommend Favorite